Nanobiotix S.A.
NBTX | NASDAQ
$34.40
-$0.10 (-0.29%)
Sep 22, 2026, 9:32 AM ET · Market open
Market Data
Market Cap $1.75B
Enterprise Value $1.53B
Beta 0.57
Average Volume 116.05K
Shares Outstanding (Diluted) 47.82M
Shares Change YoY 23.19%
Institutional Ownership 11.92%
Exchange NASDAQ
ISIN US63009J1079
Price Performance
Price Change 1M -15.3%
Price Change 3M -5.7%
Price Change 6M 12.6%
Price Change YTD 55.9%
Price Change 1Y 168.3%
Price Change 3Y 307.3%
Price Change 5Y 191.6%
1M CAGR (ann.) -9.7%
1Y CAGR (ann.) 180.3%
5Y CAGR (ann.) 23.5%
All-Time CAGR 13.1%
Valuation
PE Ratio -60.86
Forward PE 185.27
PEG Ratio -0.64
Forward PEG -5.19
PS Ratio 51.94
Forward PS 27.40
PB Ratio -17.59
P/FCF Ratio -45.33
P/Adj. FCF Ratio -41.05
P/OCF Ratio -43.47
EV/Sales 51.57
EV/EBIT -112.71
EV/EBITDA -126.68
EV/FCF -45.00
Earnings Yield -1.7%
FCF Yield -2.2%
Adj. FCF Yield -2.5%
Financial Health
Net Debt €39.47M
Total Debt €95.32M
Cash & Short-Term Investments €52.75M
Total Assets €67.76M
Current Ratio 1.09
Quick Ratio 1.09
Debt / Equity Ratio -1.13
Debt / EBITDA -7.90
Debt / FCF -2.81
OCF / Debt -0.35
Interest Coverage -1.04
Altman Z-Score 5.23
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -36.5%
EBITDA Margin -40.7%
Net Profit Margin -80.8%
FCF Margin -114.6%
Adj. FCF Margin -126.5%
SBC / Revenue 11.9%
SBC Impact (per share) -10.4%
Returns
Return on Assets -35.4%
Return on Equity 31.2%
Return on Invested Capital -74.3%
Return on Capital Employed -105.5%
Return on Tangible Assets -35.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 658.2%
Revenue CAGR 5Y 49.2%
Revenue CAGR 10Y 60.2%
EPS CAGR 3Y 43.4%
EPS CAGR 5Y 23.8%
EPS CAGR 10Y 5.6%
FCF CAGR 3Y -5.2%
FCF CAGR 5Y 2.3%
FCF CAGR 10Y -0.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y -22.0%
Revenue Growth Next 3Y -34.2%
Earnings Date Sep 28, 2026
EPS Estimate (next Q) -$0.55
EPS Growth Est (next Q) 262.5%
Revenue Est (next Q) $1.98M
Revenue Growth Est (next Q) -94.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $38
Price Target Upside 10.1%
Cash Flow
Operating Cash Flow €-33.42M
Free Cash Flow €-33.97M
Adj. Free Cash Flow €-37.51M
FCF Per Share -$0.72
OCF Per Share -$0.70
OCF/S Ratio -112.7%
Income Statement
Revenue €29.64M
Gross Profit €29.64M
Operating Income €-10.82M
EBITDA €-12.07M
Net Income €-23.96M
EPS (Diluted) -$0.50
Revenue / Employee $305.6K
Profit / Employee $-247.02K
Employees 97
Add to Watchlist
Select watchlists to add or remove NBTX